Therapeutic Potential of Bowman-Birk Inhibitors in Various Disorders: A Comprehensive Review

No abstract is available for this paper.

• Publication year

  2025

• Venue

  European Journal of Medicinal Chemistry Reports

• Publication date

  2025-11-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.ejmcr.2025.100310
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Carotenoids as neuroprotective agents in multiple sclerosis: Pathways, mechanisms, and clinical prospects.

  2025cited by this paper
• The Impact of Soy Products and Isoflavones on Male Reproductive Hormones: A Systematic Review and Dose–Response Meta‐Analysis of Randomized Controlled Trials

  2025cited by this paper
• Effects of Pomegranate on Vascular Endothelial Function: A Systematic Review and Meta-Analysis of Clinical Trials

  2025cited by this paper
• Therapeutic proteins: developments, progress, challenges, and future perspectives

  2024cited by this paper
• Evidence that the Bowman-Birk inhibitor from Pisum sativum affects intestinal proteolytic activities in chickens

  2023cited by this paper
• Chia (Salvia hispanica L.) Seeds Contain a Highly Stable Trypsin Inhibitor with Potential for Bacterial Management Alone or in Drug Combination Therapy with Oxacillin

  2022cited by this paper
• Role of Serine Proteases at the Tumor-Stroma Interface

  2022cited by this paper
• Tight Junctions, the Key Factor in Virus-Related Disease

  2022cited by this paper
• Challenges in delivering therapeutic peptides and proteins: A silk-based solution.

  2022cited by this paper
• Potential utility of peptides against damage induced by ionizing radiation.

  2021cited by this paper
• OUP accepted manuscript

  2021cited by this paper
• The trypsin inhibitor from Moringa oleifera flowers (MoFTI) inhibits acute inflammation in mice by reducing cytokine and nitric oxide levels

  2021cited by this paper
• Proteases, protease inhibitors and radiation carcinogenesis

  2021cited by this paper
• High Expression of PRSS3 Indicates Unfavorable Clinical Outcomes in Colon Adenocarcinoma

  2021cited by this paper
• Investigating the role of Bowman-Birk serine protease inhibitor in Arabidopsis plants under drought stress.

  2020cited by this paper
• A fungal effector and a rice NLR protein have antagonistic effects on a Bowman–Birk trypsin inhibitor

  2020cited by this paper
• Inactivation of mesotrypsin by chymotrypsin C prevents trypsin inhibitor degradation

  2020cited by this paper
• Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics

  2020cited by this paper
• Blood pressure-lowering effects of a Bowman-Birk inhibitor and its derived peptides in normotensive and hypertensive rats

  2020cited by this paper
• Bowman-Birk Inhibitors: Insights into Family of Multifunctional Proteins and Peptides with Potential Therapeutical Applications

  2020cited by this paper
• In vivo anti‐inflammatory efficacy of the combined Bowman‐Birk trypsin inhibitor and genistein isoflavone, two biological compounds from soybean

  2019cited by this paper
• A Bowman-Birk Inhibitor from the Seeds of Luetzelburgia auriculata Inhibits Staphylococcus aureus Growth by Promoting Severe Cell Membrane Damage.

  2018cited by this paper
• Role of soybean-derived bioactive compounds in inflammatory bowel disease

  2018cited by this paper
• Harnessing Protease Activity to Improve Cancer Care

  2018cited by this paper
• Bowman‒Birk Inhibitor Suppresses Herpes Simplex Virus Type 2 Infection of Human Cervical Epithelial Cells

  2018cited by this paper
• Biochemical properties of a bacterially-expressed Bowman-Birk inhibitor from Rhynchosia sublobata (Schumach.) Meikle seeds and its activity against gut proteases of Achaea janata.

  2018cited by this paper
• UniProt: a worldwide hub of protein knowledge

  2018cited by this paper
• Serine protease inhibitors to treat inflammation: a patent review (2011-2016)

  2018cited by this paper
• The role of matrix metalloproteinases in aging: Tissue remodeling and beyond.

  2017cited by this paper
• Role of Serine Proteases and Inhibitors in Cancer

  2017cited by this paper
• Proteases in Human Diseases

  2017cited by this paper
• Synergistic Activity between Two Antifungal Proteins, the Plant Defensin NaD1 and the Bovine Pancreatic Trypsin Inhibitor

  2017cited by this paper
• Epithelial expression and function of trypsin-3 in irritable bowel syndrome

  2017cited by this paper
• Corrigendum: Soybean-derived Bowman-Birk Inhibitor (BBI) Inhibits HIV Replication in Macrophages

  2016cited by this paper
• A Bowman–Birk inhibitor induces apoptosis in human breast adenocarcinoma through mitochondrial impairment and oxidative damage following proteasome 20S inhibition

  2016cited by this paper
• 9 Chitin Synthesis and Fungal Cell Morphogenesis

  2016cited by this paper
• The Significance of Matrix Metalloproteinases in Oral Diseases.

  2016cited by this paper
• The Degradome database: expanding roles of mammalian proteases in life and disease

  2015cited by this paper
• Effect of salinity stress on plants and its tolerance strategies: a review

  2015cited by this paper
• Physiological and proteome analysis suggest critical roles for the photosynthetic system for high water-use efficiency under drought stress in Malus.

  2015cited by this paper
• Pea (Pisum sativum L.) seed albumin extracts show anti-inflammatory effect in the DSS model of mouse colitis.

  2015cited by this paper
• Bowman-Birk inhibitors from legumes as colorectal chemopreventive agents.

  2014cited by this paper
• Effects of an Anticarcinogenic Bowman-Birk Protease Inhibitor on Purified 20S Proteasome and MCF-7 Breast Cancer Cells

  2014cited by this paper
• Soybean Bowman-Birk protease inhibitor (BBI): identification of the mechanisms of BBI suppressive effect on growth of two adenocarcinoma cell lines: AGS and HT29.

  2014cited by this paper
• Phase I randomized double-blind placebo-controlled single-dose safety studies of Bowman-Birk inhibitor concentrate

  2014cited by this paper
• A Bowman–Birk protease inhibitor with antifeedant and antifungal activity from Dolichos biflorus

  2013cited by this paper
• The contribution of two disulfide bonds in the trypsin binding domain of horsegram (Dolichos biflorus) Bowman-Birk inhibitor to thermal stability and functionality.

  2013cited by this paper
• Bowman Birk Inhibitor Concentrate and Oral Leukoplakia: A Randomized Phase IIb Trial

  2013cited by this paper
• Anticancer and α-chymotrypsin inhibiting diterpenes and triterpenes from Salvia leriifolia

  2013cited by this paper
• A Low Dose of Fermented Soy Germ Alleviates Gut Barrier Injury, Hyperalgesia and Faecal Protease Activity in a Rat Model of Inflammatory Bowel Disease

  2012cited by this paper
• Neutrophil serine proteases promote IL-1β generation and injury in necrotizing crescentic glomerulonephritis.

  2012cited by this paper
• Probing the soybean Bowman-Birk inhibitor using recombinant antibody fragments.

  2012cited by this paper
• Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases.

  2012cited by this paper
• Structure of catalytic domain of Matriptase in complex with Sunflower trypsin inhibitor-1

  2011cited by this paper
• Bowman–Birk inhibitor attenuates experimental autoimmune encephalomyelitis by delaying infiltration of inflammatory cells into the CNS

  2011cited by this paper
• Traditional medicine: past, present and future research and development prospects and integration in the National Health System of Cameroon.

  2011cited by this paper
• Proteases as therapeutics.

  2011cited by this paper
• Soybean-derived Bowman-Birk inhibitor inhibits neurotoxicity of LPS-activated macrophages

  2011cited by this paper
• Lunasin and Bowman-Birk protease inhibitor concentrations of protein extracts from enzyme-assisted aqueous extraction of soybeans.

  2011cited by this paper
• Protein targets of inflammatory serine proteases and cardiovascular disease

  2010cited by this paper
• The cytotoxic effect of Bowman-Birk isoinhibitors, IBB1 and IBBD2, from soybean (Glycine max) on HT29 human colorectal cancer cells is related to their intrinsic ability to inhibit serine proteases.

  2010cited by this paper
• The radioprotector Bowman-Birk proteinase inhibitor stimulates DNA repair via epidermal growth factor receptor phosphorylation and nuclear transport.

  2008cited by this paper
• Matrix metalloproteinases as modulators of inflammation.

  2008cited by this paper
• Neutrophil serine proteases fine-tune the inflammatory response.

  2008cited by this paper
• Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis.

  2008cited by this paper
• Plant Response to Water-deficit Stress

  2007cited by this paper
• Plant protease inhibitors: a defense strategy in plants

  2007cited by this paper
• Bowman-Birk Inhibitor Concentrate: A Novel Therapeutic Agent for Patients with Active Ulcerative Colitis

  2007cited by this paper
• Purification and characterization of a serine protease from Cucumis trigonus Roxburghi.

  2006cited by this paper
• The Absolute Structural Requirement for a Proline in the P3′-position of Bowman-Birk Protease Inhibitors Is Surmounted in the Minimized SFTI-1 Scaffold*

  2006cited by this paper
• The protease inhibitor, Bowman-Birk Inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis

  2006cited by this paper
• Genes and salt tolerance: bringing them together.

  2005cited by this paper
• Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1.

  2005cited by this paper
• Soybean products and reduction of breast cancer risk: a case–control study in Japan

  2005cited by this paper
• Design, synthesis and analysis of novel bicyclic and bifunctional protease inhibitors.

  2004cited by this paper
• In vitro inhibition of the activation of Pro-matrix Metalloproteinase 1 (Pro-MMP-1) and Pro-matrix metalloproteinase 9 (Pro-MMP-9) by rice and soybean Bowman-Birk inhibitors.

  2004cited by this paper
• Development of the Bowman‐Birk inhibitor for oral cancer chemoprevention and analysis of neu immunohistochemical staining intensity with Bowman‐Birk inhibitor concentrate treatment

  2003cited by this paper
• Most Effective Colon Cancer Chemopreventive Agents in Rats: A Systematic Review of Aberrant Crypt Foci and Tumor Data, Ranked by Potency

  2002cited by this paper
• Serine proteinase inhibitors in the Compositae: distribution, polymorphism and properties.

  2002cited by this paper
• Peptide mimics of the Bowman-Birk inhibitor reactive site loop.

  2002cited by this paper
• Synthetic peptide mimics of the Bowman-Birk inhibitor protein.

  2001cited by this paper
• Characterization of the amino acids essential for the photo- and radioprotective effects of a Bowman-Birk protease inhibitor-derived nonapeptide.

  2001cited by this paper
• Antifungal Activity of a Bowman–Birk‐type Trypsin Inhibitor from Wheat Kernel

  2000cited by this paper
• Bowman-Birk inhibitor suppresses production of superoxide anion radicals in differentiated HL-60 cells.

  1999cited by this paper
• The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent.

  1998cited by this paper
• Chemopreventive agents: protease inhibitors.

  1998cited by this paper
• Bowman-Birk proteinase inhibitor (BBI) modulates radiosensitivity and radiation-induced differentiation of human fibroblasts in culture.

  1995cited by this paper
• Natural protein proteinase inhibitors and their interaction with proteinases.

  1992cited by this paper
• Inflammatory Bowel Disease: Emerging Therapies and Future Treatment Strategies

  year unknowncited by this paper

• No citing papers are available for this paper.